Elanco Animal Health Reports Financial Results; Press Release Attached

What Happened

• Elanco Animal Health Inc. filed a Form 8‑K dated August 5, 2026 under Item 2.02 to report results of operations and financial condition.
• The company attached and incorporated by reference a press release (Exhibit 99.1) dated August 5, 2026 that contains the financial details (earnings/quarterly results, revenue, and related commentary). The 8‑K was signed by Robert M. VanHimbergen, Executive VP & CFO.

Key Details

• Filing date: August 5, 2026 (Form 8‑K, Accession No. 0001739104-26-000040).
• Item reported: 2.02 — Results of Operations and Financial Condition.
• Exhibit included: 99.1 — Press Release issued by Elanco Animal Health Incorporated dated August 5, 2026.
• Interactive data: 104.1 Cover Page Interactive Data File embedded in the Inline XBRL document.

Why It Matters

• This 8‑K provides Elanco’s official, SEC‑filed disclosure of recent financial performance (earnings/revenue and other results). Investors should read the attached press release for the specific numbers and management commentary that could affect the stock price and near‑term expectations.
• The filing is procedural confirmation that the company has publicly released its results; no additional corporate actions (e.g., executive changes, mergers, bankruptcies) were reported in this 8‑K.